GPI 250 mg 907 Pill - white capsule/oblong, 19mm
Pill with imprint GPI 250 mg 907 is White, Capsule/Oblong and has been identified as Penicillamine 250 mg. It is supplied by Granules Pharmaceuticals Inc.
Penicillamine is used in the treatment of Cystinuria; Rheumatoid Arthritis; Wilson's Disease and belongs to the drug class antirheumatics. There is positive evidence of human fetal risk during pregnancy. Penicillamine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GPI 250 mg 907
Penicillamine
- Imprint
- GPI 250 mg 907
- Strength
- 250 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Granules Pharmaceuticals Inc.
- National Drug Code (NDC)
- 70010-0907
See also:
More about penicillamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.